ReBalans | Medical grade sensor for continuous hydration monitoring and early detection of fluid imbalances.

Summary
Fluid disorders represent a major problem in healthcare. Especially for patients in risk of dehydration or overhydration, such
as heart and renal disease patients in hospital wards or elderly population with reduced thirst and cognitive problems.
Improper fluid management has important implications for patients, caregivers and economies: increase mortality, increase
risk of suffering co-morbidities (infections, longer hospital stays, acute kidney injuries) and increase costs (e.g. proper hydration
could lead to €1bn savings in UK per year). Current practice for fluid monitoring uses Fluid Balance Charts, which are
inaccurate, incomplete, time-consuming and cumbersome to complete. Mode Sensors developed a revolutionary solution for fluid monitoring, the Re:Balans patch sensor, a non-invasive, connected, disposable and wearable sensor for remote and continuous monitoring of body hydration. Re:Balans is built 1) with robust sensor combination to meet medical level accuracy data, and 2) to be user-friendly and fit into everyday worker and patient procedures. Re:Balans will be a game-changer in the healthcare because: 1) it has better accuracy than the best-practice method in clinical settings; 2) it is cheaper and more efficient to use than current alternatives. Re:Balans will
have a major impact by: 1) reducing unnecessary costs and casualties by preventing dehydration, such as co-morbidities,
readmission to hospital or longer hospital stays; 2) improving doctors and nurses daily activities, substituting time-consuming
measurements by automatic, remote and continuous accurate data, and 3) strengthen healthcare systems with a solution
that directly addresses the EU’s challenges of ageing population, multimorbidity and healthcare worker shortages.
In addition, Re:Balans successful development and commercialization through this project will significantly boost our growth
with accumulated revenues and profits of €107 m and €37 m, respectively, for the 5-year post project.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/969065
Start date: 01-03-2021
End date: 29-02-2024
Total budget - Public funding: 3 567 500,00 Euro - 2 497 250,00 Euro
Cordis data

Original description

Fluid disorders represent a major problem in healthcare. Especially for patients in risk of dehydration or overhydration, such
as heart and renal disease patients in hospital wards or elderly population with reduced thirst and cognitive problems.
Improper fluid management has important implications for patients, caregivers and economies: increase mortality, increase
risk of suffering co-morbidities (infections, longer hospital stays, acute kidney injuries) and increase costs (e.g. proper hydration
could lead to €1bn savings in UK per year). Current practice for fluid monitoring uses Fluid Balance Charts, which are
inaccurate, incomplete, time-consuming and cumbersome to complete. Mode Sensors developed a revolutionary solution for fluid monitoring, the Re:Balans patch sensor, a non-invasive, connected, disposable and wearable sensor for remote and continuous monitoring of body hydration. Re:Balans is built 1) with robust sensor combination to meet medical level accuracy data, and 2) to be user-friendly and fit into everyday worker and patient procedures. Re:Balans will be a game-changer in the healthcare because: 1) it has better accuracy than the best-practice method in clinical settings; 2) it is cheaper and more efficient to use than current alternatives. Re:Balans will
have a major impact by: 1) reducing unnecessary costs and casualties by preventing dehydration, such as co-morbidities,
readmission to hospital or longer hospital stays; 2) improving doctors and nurses daily activities, substituting time-consuming
measurements by automatic, remote and continuous accurate data, and 3) strengthen healthcare systems with a solution
that directly addresses the EU’s challenges of ageing population, multimorbidity and healthcare worker shortages.
In addition, Re:Balans successful development and commercialization through this project will significantly boost our growth
with accumulated revenues and profits of €107 m and €37 m, respectively, for the 5-year post project.

Status

CLOSED

Call topic

EIC-SMEInst-2018-2020

Update Date

26-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.0. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Cross-cutting calls
H2020-EIC-SMEInst-2018-2020
H2020-EIC-SMEInst-2018-2020-3
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.0. INDUSTRIAL LEADERSHIP - Innovation In SMEs - Cross-cutting calls
H2020-EIC-SMEInst-2018-2020
H2020-EIC-SMEInst-2018-2020-3
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.0. Cross-cutting call topics
H2020-EIC-SMEInst-2018-2020
H2020-EIC-SMEInst-2018-2020-3